Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Coeur Commences Drilling at Silver North's Tim Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Mast Therapeutics MSTX

Healthcare Biotechnology
"Mast Therapeutics Inc is a biopharmaceutical company developing clinical-stage therapies for serious or life-threatening diseases with significant unmet needs. Its product candidate, AIR001, a sodium nitrite solution for inhalation via nebulization."

Recent & Breaking News (NYSEAM:MSTX)

Mast Therapeutics Announces Agreement With Philips For Supply Of Adaptive Aerosol Delivery System For AIR001

PR Newswire October 17, 2016

Mast Therapeutics To Present At 2016 BIO Investor Forum On October 19th

PR Newswire October 13, 2016

Mast Therapeutics Provides Business Update

PR Newswire September 26, 2016

Mid-Afternoon Market Update: Dow Surges 125 Points; FedEx Shares Jump Following Upbeat Earnings

Benzinga.com  September 21, 2016

12 Biggest Mid-Day Losers For Wednesday

Benzinga.com  September 21, 2016

Mid-Morning Market Update: Markets Open Higher; General Mills Earnings Top Views

Benzinga.com  September 21, 2016

Mast Therapeutics Reports Top-Line Results From Phase 3 Study In Sickle Cell Disease

PR Newswire September 20, 2016

Watch These 7 Huge Call Purchases In Monday Trade

Benzinga.com  September 19, 2016

Martin Shkreli Thinks Jazz Pharmaceuticals Could Be Worth $20 Billion, While Mast Therapeutics Is 'Worthless'

Benzinga.com  September 12, 2016

Watch These 7 Huge Call Purchases In Thursday Trade

Benzinga.com  September 1, 2016

11 Biopharma CEOs To Follow On Twitter

Benzinga.com  August 18, 2016

15 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  July 26, 2016

Mast Therapeutics Receives Notice Of Allowance Of Composition Of Matter Patent Application Covering Vepoloxamer

PR Newswire June 8, 2016

Results of Vepoloxamer Nonclinical Studies in Advanced Heart Failure Presented at European Society of Cardiology 3rd World Congress on Acute Heart Failure

PR Newswire May 23, 2016

Positive Interim Results From Second Phase 2a Study Of AIR001 In Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) Presented At American Thoracic Society International Conference

PR Newswire May 16, 2016

Mast Therapeutics Reports First Quarter 2016 Financial Results And Recent Highlights

PR Newswire May 6, 2016

Mast Therapeutics Announces Agreement For Phase 2 Study Of AIR001 To Be Conducted By The Heart Failure Clinical Research Network

PR Newswire April 13, 2016

Four Trending Stocks Investors Are Watching On Wednesday 4/6/2016

Accesswire April 6, 2016

Results Of Vepoloxamer Nonclinical Studies In Advanced Heart Failure Presented At American College Of Cardiology 65th Annual Scientific Sessions & Expo

PR Newswire April 4, 2016

Mast Therapeutics Reports Fourth Quarter And Full Year 2015 Financial Results

PR Newswire March 14, 2016